Will Cannabis Genetics Be Banned?

A redefinition of hemp under national law, scheduled to take place Nov. 12, signals the end of Farm Bill protections for numerous hemp-derived THC items across the country: low-dose beverages as well as THCA flower and delta-8 THC gummies, vapes and other products sold at gas stations and smoke shops.

But the hemp prohibition also generates a major complication for the legal cannabis industry. Seeds from cannabis cultivars that generate flower with greater than 0.3% THC are no longer legal to transport out of state.

Although seed purchases will likely continue in legal states, the changes threaten to close some seed banks and genetics businesses, observers say, while causing supply-chain issues for cannabis cultivators and retailers.

"If this wording goes forward, we will need pop-up shops to sell seeds in every state where it's legal," Campanella said. "Which is why we're also offering clones and tissue cultivation, because that's not included in the bill."

When are cannabis seeds and clones illegal to ship between state lines?

The updated regulations categorize seeds depending on the THC capacity of the mother plant. Genetic material such as seeds and clones are made illegal if the end product exceeds the threshold.

For the moment, seeds are currently shipping under the 2018 Farm Bill's current quo. But the time is ticking for enterprises like Brothers Grimm and for cannabis cultivators who worry about supply chain interruptions if out-of-state availability to genetics is prohibited.

Most of the cannabis industry remains mostly unaware of the approaching shutdown of the interstate genetics market, said Ryan Power, co-founder of Sebastopol, California-based company Atlas Seed.

Without government intervention in the way of a carve-out for https://nativesusa.com/ (nativesusa.com) seeds or an overall moratorium, numerous seed suppliers will just be shuttered by November, he added.

"We are functioning legally currently, but if that shifts, it will upend the legal licensed sector in every state," said Power, whose clientele includes seed banks as well as licensed business cultivators.

"Consumers are going to lose choice, and it will be a significant shutdown for most people."

What are cannabis seed suppliers doing to remain legal after the federal hemp ban?

Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which tightened cannabis oversight in that state while also limiting hemp-derived THC products to licensed cannabis retailers.

Formerly a seed supplier, Silberhaze is now focused on the branding, preservation and IP safeguarding of elite plant genetics.

That's because seed businesses hoping to remain compliant in this new environment must have solid documentation, he said.

"You have to prove where this material comes from, so it's very important to have records, even to the extent where you have cultivator names," Silber said.

"Small businesses will have to work with improved records and a better chain of custody," he added. "We need that documentation too, because we don't want to be dealing with shady sources."

To avoid seizures and additional legal consequences, seed entrepreneurs must "get their affairs in order" before the new regulations take effect, Silber said.

"Review all your materials immediately, and categorize what you can," Silber said. "Take stock, document your lineage, preserve cultivator records, and arrange any cannabinoid or terpene information you already have. If regulations change, you'll be in a far better position to comprehend what may be impacted and make informed decisions."

Does federal marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration licensing may be required for companies engaged in research.

But for the time being, seed houses can't register with the DEA like state-licensed medical cannabis operators can. Such a pathway is unavailable to seed banks, nurseries or genetics companies, said Jim Ickes, an attorney and partner with Frantz Ward's cannabis practice group in Cleveland.

"Genetics activity may be occurring inside broader state-licensed medical marijuana businesses, as some states permit dispensaries or registered therapeutic operators to offer seeds, clones or home-cultivation materials," he said.

"But that is different from the DEA creating a freestanding seed bank registration category."

Some genetics companies are currently changing operational practices to conform with the updated law. According to Ickes, they must answer questions including:

• Which of our lines produce plants over 0.3% total THC?
• Which seeds remain as hemp after Nov. 12, 2026, and which don't?
• What does our catalog look like once we organize it against the genetics exclusion?

Ickes also recognizes confusion from customers who believed government rescheduling of therapeutic marijuana would resolve their situation with banking institutions. However, the latest regulatory language has moved those conversations beyond the basics of classification, he said.

"Financial institutions ask whether this specific revenue source is lawful, whether it ties to state-licensed operations, or whether there's interstate-commerce risk," said Ickes.

"After November, a seed bank selling drug-type genetics can't address the first question with the hemp definition. It has to point to a lawful state cannabis channel instead. Seed banks dealing in genuine industrial-hemp seed keep the simpler story."

What's the outlook of cannabis genetics?

Campanella is part of a emerging coalition of fellow breeders, farmers and researchers that's arguing seeds are better defined as agricultural inputs than regulated substances. To that end, seeds should be managed by the U.S. Department of Agriculture, allowing the DEA to concentrate its enforcement work elsewhere.

"How do you regulate something based on what it could become later?" said Campanella. "Our choice is to have that language removed, or get seeds regulated by the USDA as a hemp product."

But in the meantime, Campanella is reorganizing Brothers Grimm to operate outside the scope of changing federal oversight. The business plans to maintain its Colorado seed operation while placing its Oklahoma tissue cultivation facility as a hedge against government prohibition of cannabis seeds.

As she noted: "If things evolve in a way where we can't concentrate on interstate shipping, we'll have additional resources to satisfy people's requirements without putting ourselves in trouble."